11 October 2021 at 9:15am

09:15
“A pilot pharmacist-led medication reconciliation and medication review service for psychotropic substance abusers and rehabilitees in Hong Kong”
by Ms CHU Kwok Pui

09:35
“Use and effectiveness of lipid-modifying drugs”
by Mr. BLAIS Edgar Joseph

09:55
“Risk factors of peritoneal dialysis-associated peritonitis in Hong Kong: a population-based study”
by Mr. CHENG Wing Tak

10:15
“The potential effects of Mirabegron on extended potential stem cell (EPSC)-derived beige adipocytes--as a new therapeutic drug for metabolic disease”
by Ms CHENG Ying

10:35
“Role of endothelial SIRT1 in the regulation of circadian rhythmicity”
by Mr. FU Bowen

10:55
“Effectiveness and safety of continuous use of LMWH versus switching to NOACs in patients with CAT”
by Ms KANG Wei

11:15
“Optochemical control of cell cycle by opto-PROTAC”
by Mr. WANG Tianyi

11:35
“Neutrophil serine proteases as the endogenous suppressors of white adipose browning and adaptive thermogenesis in obesity”
by Ms YUAN Lufengzi

11:55
“Reactive oxygen species-responsive cinnamaldehyde polymeric prodrugs for rheumatoid arthritis therapy”
by Ms ZHANG Yaming

12:15
“Impotance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: a discrete choice experient”
by Mr. ZHAO Jiaxi

12:35
“Regulatory role of androgens in adipose fibrosis”
by Ms ZHAO Jiayu